Daniel E Davis, MD in Shelby, NC - Medicare Internal Medicine

Daniel E Davis, MD is a medicare enrolled "Internal Medicine" physician in Shelby, North Carolina. He went to Wake Forest University School Of Medicine and graduated in 1993 and has 31 years of diverse experience with area of expertise as Internal Medicine. He is a member of the group practice Carolinas Physicians Network Inc and his current practice location is 807 Schenck St, Ste 2, Shelby, North Carolina. You can reach out to his office (for appointments etc.) via phone at (980) 487-2540.

Daniel E Davis is licensed to practice in North Carolina (license number 200401046) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1093708414.

Contact Information

	Daniel E Davis, MD
	807 Schenck St, Ste 2, Shelby, NC 28150-5122
	(980) 487-2540
	Not Available

Physician's Profile

Full Name	Daniel E Davis
Gender	Male
Speciality	Internal Medicine
Experience	31 Years
Location	807 Schenck St, Shelby, North Carolina
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Daniel E Davis attended and graduated from Wake Forest University School Of Medicine in 1993

NPI Data:

NPI Number: 1093708414
Provider Enumeration Date: 08/31/2005
Last Update Date: 12/18/2023

Medicare PECOS Information:

PECOS PAC ID: 2062486152
Enrollment ID: I20040824000925

Medical Identifiers

Medical identifiers for Daniel E Davis such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1093708414	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207R00000X	Internal Medicine	200401046 (North Carolina)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Carolinas Physicians Network Inc	3375449655	1613

News Archive

ERH wins PRI's 2012 Best Practices in Risk Management and Patient Safety Award

Physicians' Reciprocal Insurers (PRI), the second largest medical malpractice insurer in New York state, today presented Ellenville Regional Hospital with its 2012 Best Practices in Risk Management and Patient Safety Award.

23andMe granted FDA approval to market direct-to-consumer genetic test under novel device classification

23andMe, Inc., the leading personal genetics company, today announced that it has been granted authority by the U.S. Food and Drug Administration (FDA) to market the first direct-to-consumer genetic test under a regulatory classification for novel devices.

Blood pressure treatment may prevent end-stage kidney disease in some patients: Study

Intensively treating hypertension in some African Americans with kidney disease by pushing blood pressure well below the current recommended goal may significantly decrease the number who lose kidney function and require dialysis, suggests a Johns Hopkins-led study publishing in the New England Journal of Medicine Thursday.

New research commissioned to create infection control strategy for AMR and antibiotic usage

It is the health system's nightmare, bubbling just below the surface of our hospitals. Infections are becoming more and more resistant to antibiotics, while secondary infection rates during hospital stays continue to rise.

HDAC6 enzyme could be possible target for therapies against Alzheimer's

Scientists from the DZNE sites in G-ttingen and Bonn, the UMG as well as from the US participated in this basic research project on Alzheimer's disease. The study is published in "EMBO Molecular Medicine".

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Daniel E Davis allows following entities to bill medicare on his behalf.

Entity Name	Carolinas Physicians Network Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1437607686 PECOS PAC ID: 3375449655 Enrollment ID: O20040115000819

News Archive

ERH wins PRI's 2012 Best Practices in Risk Management and Patient Safety Award

23andMe granted FDA approval to market direct-to-consumer genetic test under novel device classification

Blood pressure treatment may prevent end-stage kidney disease in some patients: Study

New research commissioned to create infection control strategy for AMR and antibiotic usage

HDAC6 enzyme could be possible target for therapies against Alzheimer's

Entity Name	The Charlotte-mecklenburg Hospital Authority
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1669738829 PECOS PAC ID: 2961310685 Enrollment ID: O20100309000605

ERH wins PRI's 2012 Best Practices in Risk Management and Patient Safety Award

23andMe granted FDA approval to market direct-to-consumer genetic test under novel device classification

Blood pressure treatment may prevent end-stage kidney disease in some patients: Study

New research commissioned to create infection control strategy for AMR and antibiotic usage

HDAC6 enzyme could be possible target for therapies against Alzheimer's

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Daniel E Davis is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Daniel E Davis, MD Po Box 19305, Charlotte, NC 28219-9305 Ph: () -	Daniel E Davis, MD 807 Schenck St, Ste 2, Shelby, NC 28150-5122 Ph: (980) 487-2540

News Archive

ERH wins PRI's 2012 Best Practices in Risk Management and Patient Safety Award

23andMe granted FDA approval to market direct-to-consumer genetic test under novel device classification

Blood pressure treatment may prevent end-stage kidney disease in some patients: Study

New research commissioned to create infection control strategy for AMR and antibiotic usage

HDAC6 enzyme could be possible target for therapies against Alzheimer's

Internal Medicine Doctors in Shelby, NC

Renee B. Melton-smith, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 807 Schenck St, Ste 2, Shelby, NC 28150 Phone: 980-487-2540
Kyle Anthony Aldinger, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 711 N Dekalb St, Shelby, NC 28150 Phone: 704-482-1482 Fax: 704-480-6012
Osaguona Osa, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 E Grover St, Shelby, NC 28150 Phone: 980-487-3678 Fax: 980-487-2222
Paul Brent Ferrell, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 711 N Dekalb St, Shelby, NC 28150 Phone: 704-482-1482 Fax: 704-480-6012
Aamir Iqbal, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 711 N Dekalb St, Shelby, NC 28150 Phone: 704-482-1482
Forrest Leigh Thompson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 E Grover St, Shelby, NC 28150 Phone: 980-487-2600
Donnielle Lynn Green, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 951 Wendover Height Dr, Shelby, NC 28150 Phone: 704-487-4677 Fax: 704-887-6450

Daniel E Davis, MD - Medicare Internal Medicine in Shelby, NC

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

ERH wins PRI's 2012 Best Practices in Risk Management and Patient Safety Award

23andMe granted FDA approval to market direct-to-consumer genetic test under novel device classification

Blood pressure treatment may prevent end-stage kidney disease in some patients: Study

New research commissioned to create infection control strategy for AMR and antibiotic usage

HDAC6 enzyme could be possible target for therapies against Alzheimer's

Medicare Reassignments

ERH wins PRI's 2012 Best Practices in Risk Management and Patient Safety Award

23andMe granted FDA approval to market direct-to-consumer genetic test under novel device classification

Blood pressure treatment may prevent end-stage kidney disease in some patients: Study

New research commissioned to create infection control strategy for AMR and antibiotic usage

HDAC6 enzyme could be possible target for therapies against Alzheimer's

ERH wins PRI's 2012 Best Practices in Risk Management and Patient Safety Award

23andMe granted FDA approval to market direct-to-consumer genetic test under novel device classification

Blood pressure treatment may prevent end-stage kidney disease in some patients: Study

New research commissioned to create infection control strategy for AMR and antibiotic usage

HDAC6 enzyme could be possible target for therapies against Alzheimer's

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

ERH wins PRI's 2012 Best Practices in Risk Management and Patient Safety Award

23andMe granted FDA approval to market direct-to-consumer genetic test under novel device classification

Blood pressure treatment may prevent end-stage kidney disease in some patients: Study

New research commissioned to create infection control strategy for AMR and antibiotic usage

HDAC6 enzyme could be possible target for therapies against Alzheimer's

Internal Medicine Doctors in Shelby, NC